Loading clinical trials...
Loading clinical trials...
Virtual Reality Assisted Conscious Sedation During Transcatheter Aortic Valve Implantation - a Randomized Pilot Study
Transcatheter aortic valve implantation (TAVI) is an established therapy for patients with severe aortic valve stenosis. Pain and anxiety are major contributors to procedural complications. Virtual Reality (VR) glasses have already been used successfully in different clinical settings to treat anxiety and delirium. The aim of this prospective, randomized investigation is to prove the feasibility and safety of VR interventions in patients undergoing conscious sedation during TAVI with local anesthesia only.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Division of Cardiology, Pulmonary Disease and Vascular Medicine
Düsseldorf, Germany
Start Date
November 1, 2019
Primary Completion Date
June 1, 2020
Completion Date
June 1, 2020
Last Updated
June 18, 2020
20
ACTUAL participants
VR during TAVI
OTHER
Lead Sponsor
Klinik für Kardiologie, Pneumologie und Angiologie
NCT06346132
NCT07482709
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07351968